Symposium
“Intelligent Oncology – The Potential of AI to Control Cancer“
MISSION
Bringing together experts from various disciplines to explore the latest advances in AI-assisted cancer research. Our goal is to promote collaboration between researchers, physicians, industry leaders, and other visionaries in the field. By sharing knowledge and expertise, we aim to discover new ways to control cancer through the power of AI.
–
AIM OF THE CONFERENCE
The theme of the conference is Intelligent Oncology, focusing on harnessing the power of AI to control cancer. Our aim is to present cutting-edge research and innovative approaches in cancer diagnosis, prognosis, and treatment. We aim to identify new research directions, foster collaborations between academia and industry, and facilitate the translation of research findings into clinical practice. By connecting experts in the field, we aim to accelerate progress towards more effective and personalized cancer treatment.
–
AREAS OF FOCUS
AI in cancer diagnosis/treatment
Computational methods for cancer research
Precision medicine with AI
Ethical, regulatory and governance issues of AI for health
Clinical translation of AI health interventions
Innovative AI technologies/platforms
Interdisciplinary collaborations in cancer
–
SCIENTIFIC BOARD
Prof. Dr. Dr. Melanie Börries
CRIION Scientific Director Systems Medicine & Medical Center, University of Freiburg
Prof. Dr. Mascha Binder
CRIION Scientific Director Clinical Oncology & University Hospital Basel
Prof. Dr. Joschka Boedecker
CRIION Scientific Director AI & Department of Computer Science, University of Freiburg
Assoc. Prof. Victor Greiff
University of Oslo, Norway
Dr. Maria Kalweit
CRIION Head of Applied AI Research & Department of Computer Science, University of Freiburg
Dr. Gabriel Kalweit
CRIION Head of Fundamental AI Research & Department of Computer Science, University of Freiburg
Prof. Christoph Merten
EPFL, Switzerland
Dr. Jan Moritz Middeke
University Hospital Dresden, Germany
Prof. em. Dr. Dr. h.c. mult. Roland Mertelsmann
CEO Mertelsmann Foundation & Medical Center, University of Freiburg
Prof. Dr. Adriana Tomic
Boston University, USA
Prof. Dr. Evelyn Ullrich
Goethe University, Ullrich Lab – Laboratory for Experimental Immunology & Cell Therapy, Germany
Prof. Dr. Robert Zeiser
CRIION Scientific Director Translational Oncology & Medical Center, University of Freiburg
–
PROGRAM 2024
9:30 – 9:50
Introduction
(Prof. Dr. Roland Mertelsmann, Prof. Dr. Joschka Boedecker, CRIION Freiburg, Germany,
Prof. Dr. Evelyn Ullrich, Goethe University, Ullrich Lab Frankfurt)
9:50 – 10:05
With Trustworthy and Applicable AI Towards Cancer Control (Dr. Maria Kalweit, CRIION, Freiburg, Germany)
10:30 – 12:10
Session 1: Understanding Cancer Through AI and Computational Biology
This session will explore how AI and computational biology can improve our understanding of cancer.
Chair: Prof. Dr. Robert Zeiser, Univerisity of Freiburg, Germany, Prof. Dr. Adriana Tomic, Boston University, USA
Knowledge-based machine learning to extract disease mechanisms from multi-omics data
(Prof. Julio Saez-Rodriguez, Universität Heidelberg, Germany)
Improving cell segmentation in spatial transcriptomics (Dr. Daniel Jones, Fred Hutch Cancer Center, USA)
Exploring mechanisms and functional heterogeneity in cellular immunotherapies targeting cancer via machine learning analysis of live-imaging (Dr. Maria Alieva, Instituto de Investigaciones Biomédicas de Madrid, Spain)
13:10 – 14:50
Session 2: Building Trust and Regulation in Artificial Intelligence Models for Medicine
This session will examine how to incorporate trust and regulatory to the development and deployment of AI and computational biology-powered cancer therapies.
Chair: Prof. Dr. Joschka Boedecker, Univerisity of Freiburg, Germany, Dr. Jan Moritz Middeke, University Hospital Dresden, Germany
New regulatory thinking is needed for ‘at-the-patient-bedside’ AI-based personalised drug and cell therapies in precision oncology
(Prof. Steven Gilbert, Technische Universität Dresden, Germany )
An instrument like any other? Ethical considerations on the use of AI in medicine
(Dr. Markus Herrmann, NCT Heidelberg, Germany)
A regulator’s perspective on AI-based indications for anti-cancer medicines (Dr. Harald Enzmann, BFARM, Germany)
15:20 – 17:10
Session 3: Deploying AI and Computational Biology into Clinical Applications
In this session, speakers will discuss the challenges and opportunities of translating AI and computational biology into clinical practice for cancer diagnosis, prognosis, and treatment.
Chair: Prof. Dr. Melanie Börries, University of Freiburg, Germany, Prof. Christoph Merten, EPFL, Switzerland,
The practical usage of AI Applications in routine diagnostics (Sven Maschek, MLL Münchner Leukämieabor, Germany)
AI for better Cancer Care (Dr. Andre Dekker, Maastricht University Medical Center, Netherlands)
Machine Learning for Personalized Cancer Care (Prof. Adam Yala, Berkeley, USA)
–
CALL FOR ABSTRACTS
Are you a PhD candidate or Postdoc working in research fields that could foster the fight against cancer with Al?
Show what you are working on at the event „Intelligent Oncology – The Potential of Al to Control Cancer“ on September 6th, 2024 in Freiburg! A scientific committee will select abstracts for poster or oral presentation. The top abstracts will receive a EUR 500 award. All presenters are welcome to participate free of charge.
Submit your abstract as PDF until July, 30th to posters@intelligent-oncology.org
–
REGISTRATION
–
–
Credits
You receive 8 credits from Landesärztekammer Baden – Württemberg.
–
SPEAKERS
–
Prof. Adam Yala
Berkeley and UCSF, USA
–
–
Dr. Andre Dekker
Maastricht University Medical
Center, Netherlands
–
–
Dr. Maria Alieva
Instituto de Investigaciones Biomédicas de Madrid, Spain
–
–
Dr. Harald Enzmann
BfArM, Germany
–
–
Prof. Julio Saez-Rodriguez
Universität Heidelberg, Germany
–
–
Prof. Steven Gilbert
Technische Universität Dresden, Germany
–
–
Sven Maschek
MLL Münchener Leukämielabor, Germany
–
